Stockreport

Veracyte's Decipher Prostate Test Receives Highest Evidence-Level Rating Among Molecular Tests in Updated Prostate Cancer NCCN Guidelines [Yahoo! Finance]

Veracyte, Inc.  (VCYT) 
Last veracyte, inc. earnings: 2/25 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.veracyte.com/investor-relations
PDF that its Decipher Prostate Genomic Classifier is the only gene expression test to receive a "Level 1B" evidence rating in the 2024 NCCN Clinical Practice Guidelines in O [Read more]